ecancermedicalscience

Erratum

Erratum: RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

7 Aug 2020
Fernando Petracci, Gonzalo Gomez Abuin, Alejandra Pini, Matías Chacón

On page 3, the number 72.5 in the following sentence replaces the number 37.5 which was incorrect:

'The Overall CB was 82.5%, higher in first line than in second line, 85.9% and 62.5%, respectively. The ORR in first line were: 4.7% CR, 40.6% PR and 40.6% SD. In second line the ORR were: 25% PR, 37.5% SD and no CR.'

Related Articles

María Valeria Jiménez-Báez, Sofía Concepción Thomas-Gómez, Gabriel González-Guerrero, David Rojano-Mejía, Eduardo Patricio Achurra-Godinez
Berthe Sabine Esson Mapoko, Etienne Atenguena, Abdel Nasser Nsangou Moun, Esther Dina Bell, Lionel Tabola, Dominique Anaba, Anne Sango, Rachel Tayou
Liudmila Castelo David, Teresa Mota Garcia, Isaulina Barreto, Esperança Carvalho, Laurinda Barreto, Clara Aleydis, Laurinda Coelho, Lúcio Lara Santos
Sree Siva Kumar Raja Addagalla, Vanita Noronha, Nandini Menon, Minit Shah, Amit Joshi, Anokhi Shah, Kumar Prabhash